Cubist Pharmaceuticals (CBST +3.1%) moves up today after reporting an in-line Q4 on a 16% jump...


Cubist Pharmaceuticals (CBST +3.1%) moves up today after reporting an in-line Q4 on a 16% jump in total sales. Net earnings more than quintupled however, as the drug developer racked up much stronger sales, and last year's results were weighed down by higher income-tax provisions. Sales of Cubicin, an intravenous antibiotic for skin and bloodstream infections, jumped 14% to $216M in the U.S.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs